Company
Sanofi
1,973 Legal Matters
62
1,524
387

Sanofi Company IP News and Updates

Mikele Bicolli
US Supreme Court's Ruling in Amgen v Sanofi Sets Precedent for Patent Enablement
Mikele Bicolli
May 19, 2023
The recent judgment in Amgen v Sanofi by the United States Supreme Court has generated significant attention within the legal...
Read More
Mikele Bicolli
The U.S. Supreme Court is About to Ultimately Decide Amgen vs Sanofi Antibody Patent Case
Mikele Bicolli
Nov 9, 2022
Most of the community involved in life science litigation and pharmaceutical companies, thought they saw the end of the long-fought...
Read More
Knobbe Martens
Expiration of Patent Does Not Always Trigger Application of Phillips Standard on IPR Appeal
Knobbe Martens
Oct 17, 2020
MMUNEX CORPORATION v. SANOFI-AVENTIS U.S. LLC Before Prost, Reyna, and Taranto.  Appeal from the Patent Trial and Appeal Board. Summary:...
Read More
Pedram Sameni
Patexia Insight 78: Patent Firms with the Largest Growth and Decline (2020)
Pedram Sameni
Mar 26, 2020
Earlier this month, we released our 2nd Annual Patent Prosecution Intelligence Report where we ranked the top patent firms based...
Read More
Knobbe Martens
Disclaimed Patent Claims Fail to Give Rise to an Article III Case or Controversy
Knobbe Martens
Aug 20, 2019
SANOFI-AVENTIS U.S., LLC v. FRESENIUS KABI USA, LLC Before Lourie, Moore, and Taranto.  Appeal from the United States District Court...
Read More
Knobbe Martens
SANOFI, SANOFI-AVENTIS U.S., LLC V. WATSON LABS. INC., SANDOZ, INC.
Knobbe Martens
Nov 18, 2017
Federal Circuit Summaries Before PROST, WALLACH, and TARANTO.  Appeal from the District of Delaware Summary: (1) A party may not...
Read More
Peter Heuser
Fresh From the Bench: Precedential Patent Cases From the Federal Circuit
Peter Heuser
Nov 11, 2017
In Sanofi v. Watson Labs., the Circuit affirms a determination of induced infringement of one patent and direct infringement of...
Read More
Warren Woessner
The End of the “Newly Characterized Antigen” Rule for Antibody Claims
Warren Woessner
Oct 11, 2017
In Amgen, Inc. v. Sanofi, Appeal no. 2017-1480 (Fed. Cir., Oct. 5, 2017) the Fed. Cir. panel reversed the district...
Read More
Showing 1-8 of 8 news found